SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-205422
Filing Date
2019-07-29
Accepted
2019-07-29 16:11:56
Documents
6
Period of Report
2019-07-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d782139d8k.htm 8-K 22636
2 EX-1.1 d782139dex11.htm EX-1.1 173160
3 EX-5.1 d782139dex51.htm EX-5.1 8681
4 EX-99.1 d782139dex991.htm EX-99.1 10593
5 EX-99.2 d782139dex992.htm EX-99.2 10423
6 GRAPHIC g782139g18v28.jpg GRAPHIC 3308
  Complete submission text file 0001193125-19-205422.txt   231420
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 19981305
SIC: 2834 Pharmaceutical Preparations